- Randomized noninferiority trial of 114 patients scheduled for anterior cruciate ligament repair at one Toronto hospital, using a fabricated low-risk research trial with active deception.
- Patients were invited to the fabricated trial either at a virtual preanesthesia visit in advance or on the day of surgery.
- Participation in the fabricated trial was 45% (26/58) for same-day consent versus 30% (17/56) for advance consent, and perceived coercion did not differ between groups.
- The authors conclude that same-day consent restrictions based on undue influence concerns may be a structural barrier to low-risk trial participation without empirical support.
Perioperative medicine
Research from anesthesiology, pain and critical care journals, sourced from PubMed.
Sorted by publication date, not import date. Recent filters exclude papers with only a publication year; find those under All years.
AI-generated abstract summaries can contain errors. Verify findings against the original paper before applying them to patient care.
Last successful paper check: 16 Nov 2026 17:18 UTC.
0 newly discovered papers saved; these are not necessarily published today.
2 papers awaiting AI summaries. Summary processing had an error; paper-fetch status is separate.
Background checks run while the server is active. This does not guarantee a daily run if hosting sleeps.
2 papers awaiting AI summaries. Summary processing had an error; paper-fetch status is separate.
Background checks run while the server is active. This does not guarantee a daily run if hosting sleeps.
- Single-center, patient- and assessor-blinded randomized trial of 192 women undergoing elective gynecological laparoscopic surgery, with 364 assessed.
- Participants wore passive noise-attenuating earmuffs from induction to end of surgery or received usual care, and all received dexamethasone and palonosetron.
- PONV within 48 hours occurred in 35.4% with noise isolation versus 52.1% with control (adjusted risk difference -0.179, 95% CI -0.318 to -0.040; P = 0.012).
- Authors conclude noise isolation was associated with lower PONV incidence and severity; secondary endpoints favored it after FDR correction, but adverse events and recovery quality did not differ.
- Multicentre randomised trial of 400 children aged 2 to under 7 years undergoing adenotonsillectomy at four tertiary hospitals in China.
- Children were randomised 1:1 to ventilation with a laryngeal mask airway or an endotracheal tube.
- Any perioperative respiratory adverse event occurred in 22.5% of the LMA group versus 57.5% of the ETT group (absolute risk difference -35.0 points, 95% CI -43.5 to -25.7; P<0.001).
- The authors conclude that LMA ventilation by experienced anaesthesiologists produced fewer respiratory adverse events, and neither group had serious adverse events.
- Randomized, double-blind dose-finding trial of 99 children aged 1-6 years undergoing adenotonsillectomy, with a glucose control group.
- Children received oral 10% glucose or oral esketamine at 1, 2, or 3 mg/kg, given 30 minutes before anesthesia.
- At cannulation, all esketamine doses improved sedation and analgesia (overall p < 0.001), greatest at 3 mg/kg, where median FLACC was 0.00 versus 6.00 in controls.
- The authors favored 2 mg/kg for balancing efficacy and safety, and 3 mg/kg for superior analgesia and opioid sparing (remifentanil 120 vs 240 μg, p = 0.001).
- Multicentre, randomised, double-blind trial in 873 analysed adults (914 randomised) undergoing video-assisted thoracoscopic lung resection.
- Perioperative low-dose esketamine (bolus at induction, then intra- and postoperative infusion for 48 h) was compared with normal saline.
- Chronic pain at 3 months was 14.7% with esketamine versus 21.2% with control (adjusted OR 0.62, 95% CI 0.43-0.90; P=0.013).
- A post hoc definition using NRS ≥3 during coughing also favoured esketamine (adjusted OR 0.39, 95% CI 0.19-0.84; P=0.015), and the authors report no increase in adverse effects.
- Randomized, double-blind, placebo-controlled single-center trial of 70 patients undergoing on-pump CABG.
- Patients received intranasal dexmedetomidine 1 μg/kg or saline on the night before surgery and again 30 minutes before induction.
- At 24 hours, estimated marginal mean hs-cTnT was 170.29 vs 357.29 ng/L (P < 0.001) favoring dexmedetomidine; CK-MB was also lower.
- Sleep quality scores were higher and postoperative delirium was lower (14.3% vs 37.1%; P = 0.029), but the authors call the findings preliminary.
- Protocol for a multicentre randomized controlled trial in patients aged 60 or older with anaemia (haemoglobin ≤90 g/l) undergoing surgery for hip fracture.
- Compares a liberal transfusion strategy (haemoglobin target 90 to 110 g/l) with a restrictive strategy (target 75 to 90 g/l) from randomization to discharge or 30 days.
- No efficacy results are reported; the primary outcome is a composite of death or major adverse cardiac events, adjudicated by blinded experts, with quality of life assessed at 120 days.
- The authors reduced the target sample size from 1,984 to 842 and added myocardial injury after non-cardiac surgery (MINS) to the primary outcome after recruitment fell short.